The paper by Tobin et al . in the March 2003 issue of Australasian Psychiatry says that the College decision to develop clinical practice guide-lines (CPGs) is not about enforcing standardized practice. 1 However, the authors go on to say that CPGs should be used to assess variance in practice. Use of the CPGs in this way would be a proxy for enforcing standardized practice. Variance analysis (and the 'correction' of variancereducing practice diversity) is usually associated with the monitoring of critical care pathways. These critical care pathways are quite detailed and are specific to services and clinical situations where a homogenous patient population or a well-defined clinical problem can be approached with a uniform protocol (such as preadmission, admission and discharge procedures for hip replacement surgery). Situations like this are fairly unusual in psychiatry (although a few might be identified). Critical care pathways are frequently used by institutions to enforce practice behaviour, and often to reign in costs. The design of critical care pathways is frequently informed by relevant CPGs, but variance analysis (monitoring practice deviations from the pathway) is usually reserved for evaluating the utility of the pathway, rather than the much broader application suggested by Tobin et al . The use of CPGs as variance tools is a misuse of CPGs and will lead to them coming into disrepute. Uncritical acceptance of this use will encourage groups within and outside the profession to interpret CPGs literally in order to claim support for a treatment or to limit treatment alternatives.
The CPGs are a statement of a consensus view (based on what evidence and opinion might be available) of a collection of professionals on a committee at a certain time in history, and are probably out of date as soon as they are published. The substantial use of level III, IV and V evidence in the guidelines means that the interpretation of this evidence by committee members is critical yet not infallible, thus limiting the authoritativeness of the CPGs. The CPGs have their limitations (also noted by the College CPG Programme team 2 ), including being rigid, not taking into account comorbidities, and non-medical preferences. 3 Alternatives exist that try to correct some of the weaknesses of CPGs. For example, clinical glidepaths are practice guidelines that are less rigid, appreciate the limitations of evidence-based medicine (EBM), emphasize individual patient outcomes, acknowledge the clinical context, and respect patient choice in medical decisions. 3 The more specific and dogmatic the CPGs are, the more they are likely to date and the less likely that they will be adopted by clinicians who work with a diversity of patients suffering from complex problems. Conversely, the more that CPGs outline an approach to a clinical problem or condition, with rational explanations for competing treatments, the more they are likely to be accepted. I think that CPGs are valuable but should be used as an informative, educative and training process. To me they are a departure point for further debate about advancing clinical care in a particular area. Perhaps when the next series are published, these thoughts might be considered.
